FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.3  |  FHIR Version n/a  User: [n/a]

209011000036103: injection solution dose form (AU qualifier)


    Status: retired, Primitive. Date: 30-Nov 2018. Module: Australian Medicines Terminology module

    Descriptions:

    Id Description Lang Type Status Case? Module
    170651011000036116 injection solution dose form (AU qualifier) en Fully specified name Active Case sensitive Australian Medicines Terminology module
    170652011000036110 injection solution en Synonym Active Case sensitive Australian Medicines Terminology module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    injection solution Is a injection false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Ropivacaine 0.2% (Actavis) 400 mg/200 mL injection, 200 mL bag has manufactured dose form False injection solution Inferred relationship Some
    Ropivacaine (Pfizer) 200 mg/100 mL injection, 100 mL bag has manufactured dose form False injection solution Inferred relationship Some
    Ropibam 0.2% (ropivacaine hydrochloride 40 mg / 20 mL) injection, 20 mL ampoule (trade product unit of use) has manufactured dose form False injection solution Inferred relationship Some
    Ropivacaine 1% (Kabi) 200 mg/20 mL injection, 20 mL ampoule has manufactured dose form False injection solution Inferred relationship Some
    Ropivacaine 0.2% (Actavis) 40 mg/20 mL injection, 20 mL ampoule has manufactured dose form False injection solution Inferred relationship Some
    Ropivacaine 1% (Actavis) 200 mg/20 mL injection, 20 mL ampoule has manufactured dose form False injection solution Inferred relationship Some
    Naropin 0.2% with Fentanyl 400 microgram/100 mL injection, 100 mL bag has manufactured dose form False injection solution Inferred relationship Some
    Ropibam 1% 200 mg/20 mL injection, 20 mL ampoule has manufactured dose form False injection solution Inferred relationship Some
    Ropivacaine (Sandoz) 40 mg/20 mL injection, 20 mL ampoule has manufactured dose form False injection solution Inferred relationship Some
    Ropivacaine 0.75% (Actavis) 75 mg/10 mL injection, 10 mL ampoule has manufactured dose form False injection solution Inferred relationship Some
    Naropin 0.2% with Fentanyl 200 microgram/100 mL injection, 100 mL bag has manufactured dose form False injection solution Inferred relationship Some
    Ropibam 1% 100 mg/10 mL injection, 10 mL ampoule has manufactured dose form False injection solution Inferred relationship Some
    Ropivacaine 0.75% (Kabi) 75 mg/10 mL injection, 10 mL ampoule has manufactured dose form False injection solution Inferred relationship Some
    Optiray-320 678 mg (iodine 320 mg)/mL injection, 200 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Optiray-350 741 mg (iodine 350 mg)/mL injection, 150 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Optiray-350 741 mg (iodine 350 mg)/mL injection, 200 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Optiray-350 741 mg (iodine 350 mg)/mL injection, 20 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Naropin 0.5% 100 mg/20 mL injection, 20 mL ampoule has manufactured dose form False injection solution Inferred relationship Some
    Naropin 0.5% 50 mg/10 mL injection, 10 mL ampoule has manufactured dose form False injection solution Inferred relationship Some
    Kanuma 20 mg/10 mL injection, 10 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Voluven injection, 500 mL bottle has manufactured dose form False injection solution Inferred relationship Some
    Voluven injection, 500 mL bag has manufactured dose form False injection solution Inferred relationship Some
    Zoledronic Acid (Apo) 4 mg/100 mL injection, 100 mL vial has manufactured dose form False injection solution Inferred relationship Some
    Repatha 420 mg/3.5 mL injection, 3.5 mL cartridge has manufactured dose form False injection solution Inferred relationship Some
    Aranesp 15 microgram/0.38 mL injection, 0.38 mL pen device has manufactured dose form False injection solution Inferred relationship Some
    Aranesp 50 microgram/0.5 mL injection, 0.5 mL pen device has manufactured dose form False injection solution Inferred relationship Some
    Aranesp 30 microgram/0.3 mL injection, 0.3 mL pen device has manufactured dose form False injection solution Inferred relationship Some
    Aranesp 10 microgram/0.4 mL injection, 0.4 mL pen device has manufactured dose form False injection solution Inferred relationship Some
    Aranesp 200 microgram/0.4 mL injection, 0.4 mL pen device has manufactured dose form False injection solution Inferred relationship Some
    Aranesp with Automatic Needle Guard 200 microgram/0.4 mL injection, 0.4 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Aranesp with Automatic Needle Guard 300 microgram/0.6 mL injection, 0.6 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Aranesp with Automatic Needle Guard 15 microgram/0.38 mL injection, 0.38 mL syringe has manufactured dose form False injection solution Inferred relationship Some
    Aranesp 300 microgram/0.6 mL injection, 0.6 mL pen device has manufactured dose form False injection solution Inferred relationship Some
    Aranesp with Automatic Needle Guard 500 microgram/mL injection, syringe has manufactured dose form False injection solution Inferred relationship Some
    Aranesp 500 microgram/mL injection, pen device has manufactured dose form False injection solution Inferred relationship Some
    Gonal-F Pen (follitropin alfa 32.76 microgram / 0.75 mL) injection, 0.75 mL pen device (trade product unit of use) has manufactured dose form False injection solution Inferred relationship Some
    Aranesp Sureclick 40 microgram/0.4 mL injection, 0.4 mL pen device has manufactured dose form False injection solution Inferred relationship Some
    Gonal-F Pen 300 units (21.84 microgram)/0.5 mL injection, 0.5 mL pen device has manufactured dose form False injection solution Inferred relationship Some
    Aranesp Sureclick 60 microgram/0.3 mL injection, 0.3 mL pen device has manufactured dose form False injection solution Inferred relationship Some
    Aranesp Sureclick (darbepoetin alfa 80 microgram / 0.4 mL) injection, 0.4 mL pen device (trade product unit of use) has manufactured dose form False injection solution Inferred relationship Some
    Aranesp Sureclick 150 microgram/0.3 mL injection, 0.3 mL pen device has manufactured dose form False injection solution Inferred relationship Some
    Gonal-F Pen 900 units (65.52 microgram)/1.5 mL injection, 1.5 mL pen device has manufactured dose form False injection solution Inferred relationship Some
    Aranesp Sureclick 100 microgram/0.5 mL injection, 0.5 mL pen device has manufactured dose form False injection solution Inferred relationship Some
    Aranesp Sureclick 20 microgram/0.5 mL injection, 0.5 mL pen device has manufactured dose form False injection solution Inferred relationship Some
    Humalog Kwikpen 200 units/mL injection, 3 mL pen device has manufactured dose form False injection solution Inferred relationship Some
    Hyoscine Butylbromide (SXP) 20 mg/mL injection, ampoule has manufactured dose form False injection solution Inferred relationship Some
    Cobal-B12 1 mg/mL injection, ampoule has manufactured dose form False injection solution Inferred relationship Some
    Oxycodone (WKT) (oxycodone hydrochloride 20 mg / 2 mL) injection, 2 mL ampoule (trade product unit of use) has manufactured dose form False injection solution Inferred relationship Some
    Oxycone 10 mg/mL injection, ampoule has manufactured dose form False injection solution Inferred relationship Some
    Oxycodone (Juno) 200 mg/20 mL injection, 20 mL ampoule has manufactured dose form False injection solution Inferred relationship Some
    Oxycodone (WKT) 10 mg/mL injection, ampoule has manufactured dose form False injection solution Inferred relationship Some
    Oxycone 20 mg/2 mL injection, 2 mL ampoule has manufactured dose form False injection solution Inferred relationship Some
    Oxycodone (Juno) 20 mg/2 mL injection, 2 mL ampoule has manufactured dose form False injection solution Inferred relationship Some
    Oxycodone (Wockhardt) 10 mg/mL injection, ampoule has manufactured dose form False injection solution Inferred relationship Some
    Oxycone 200 mg/20 mL injection, 20 mL ampoule has manufactured dose form False injection solution Inferred relationship Some
    Oxycodone (Wockhardt) 20 mg/2 mL injection, 2 mL ampoule has manufactured dose form False injection solution Inferred relationship Some
    Oxycodone (Juno) 10 mg/mL injection, ampoule has manufactured dose form False injection solution Inferred relationship Some
    Morphine Sulfate (Pharmalab) 10 mg/mL injection, ampoule has manufactured dose form False injection solution Inferred relationship Some
    Oxycone 50 mg/mL injection, ampoule has manufactured dose form False injection solution Inferred relationship Some
    Oxycodone (Juno) 50 mg/mL injection, ampoule has manufactured dose form False injection solution Inferred relationship Some
    Oxynorm 50 mg/mL injection, ampoule has manufactured dose form False injection solution Inferred relationship Some
    Erelzi Auto-Injector (etanercept 50 mg / 1 mL) injection, 1 mL pen device (trade product unit of use) has manufactured dose form False injection solution Inferred relationship Some
    Erelzi 50 mg/mL injection, syringe has manufactured dose form False injection solution Inferred relationship Some
    Erelzi 25 mg/0.5 mL injection, 0.5 mL syringe has manufactured dose form False injection solution Inferred relationship Some

    Start Previous Page 18 of 18


    Reference Sets

    Concept inactivation indicator reference set

    REPLACED BY association reference set

    Back to Start